Skip to search.
 TSX Up 0.37% TSX Ventures  0.00%
Streaming
Ticker Tape: On

NPS Pharmaceuticals, Inc. (NPSP)

-NasdaqGS
24.55 Down 0.30(1.21%) Apr 17, 4:00PM EDT
|After Hours : 24.55 0.00 (0.00%) Apr 17, 4:29PM EDT
Add to Portfolio
Prev Close:24.85
Open:24.72
Bid:N/A
Ask:28.00 x 200
1y Target Est:43.29
Beta:0.05
Earnings Date:May 7 - May 8 (Est.)
Day's Range:24.08 - 25.72
52wk Range:12.02 - 39.68
Volume:2,045,741
Avg Vol (3m):1,981,370
Market Cap:2.52B
P/E (ttm):N/A
EPS (ttm):-0.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NPSPDown 1.21%2.52B
ABTUp 1.43%60.07B
BIIBDown 0.32%68.68B

Key Statistics

Forward P/E (1 yr):18.05
P/S (ttm):16.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.19
Quarterly EPS Est (Mar-14) :-0.02
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):1.44

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on pa... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback